Poor recognition of HIV-1 Nef protein by CD8 T cells from HIV-1-infected children: Impact of age

Virology

Volumn 354, Issue 2, 2006, Pages 271-279

  Buseyne, Florence ^a   Scott Algara, Daniel ^a   Corre, Béatrice ^a   Porrot, Françoise ^a   Monchatre, Elizabeth ^a   Bellal, Nassima ^a   Burgard, Marianne ^b   Rouzioux, Christine ^b   Blanche, Stéphane ^c   Rivière, Yves ^a  

^a INSTITUT PASTEUR   (France)

^b UNIVERSITÉ PARIS DESCARTES   (France)

^c HÔPITAL NECKER ENFANTS MALADES   (France)

Author keywords

CD8 T cell; Children; CTL; Elispot; HIV; HIV perinatal infection

Indexed keywords

GAG PROTEIN; GAMMA INTERFERON; NEF PROTEIN; POL PROTEIN; VIF PROTEIN; VIRUS ENVELOPE PROTEIN; VIRUS PROTEIN;

ADOLESCENT; AGE DISTRIBUTION; ARTICLE; CD8+ T LYMPHOCYTE; CHILD; CONTROLLED STUDY; CORRELATION ANALYSIS; CYTOKINE PRODUCTION; CYTOTOXIC T LYMPHOCYTE; ENZYME LINKED IMMUNOSPOT ASSAY; FEMALE; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNE RESPONSE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN FUNCTION;

AGE FACTORS; ANTI-HIV AGENTS; CD8-POSITIVE T-LYMPHOCYTES; CHILD, PRESCHOOL; GENE PRODUCTS, NEF; HIV INFECTIONS; HIV-1; HUMANS; INFANT; NEF GENE PRODUCTS, HUMAN IMMUNODEFICIENCY VIRUS; RETROSPECTIVE STUDIES;

HUMAN IMMUNODEFICIENCY VIRUS 1;

EID: 33749506583     PISSN: 00426822     EISSN: 10960341     Source Type: Journal    
DOI: 10.1016/j.virol.2006.07.014     Document Type: Article

References (46)

1. Addo M.M., Yu X.G., Rathod A., et al. Comprehensive epitope analysis of human immunodeficiency virus type 1 (HIV-1)-specific T-cell responses directed against the entire expressed HIV-1 genome demonstrate broadly directed responses, but no correlation to viral load. J. Virol. 77 (2003) 2081-2092
2. Alter G., Merchant A., Tsoukas C.M., et al. Human immunodeficiency virus (HIV)-specific effector CD8 T cell activity in patients with primary HIV infection. J. Infect. Dis. 185 (2002) 755-765
3. Alter G., Hatzakis G., Tsoukas C.M., et al. Longitudinal assessment of changes in HIV-specific effector activity in HIV-infected patients starting highly active antiretroviral therapy in primary infection. J. Immunol. 171 (2003) 477-488
4. Alter G., Tsoukas C.M., Rouleau D., et al. Assessment of longitudinal changes in HIV-specific effector activity in subjects undergoing untreated primary HIV infection. AIDS (2004) 18
5. Bansal A., Sabbaj S., Edwards B.H., et al. T cell responses in HIV type 1-infected adolescent minorities share similar epitope specificities with whites despite significant differences in HLA class I alleles. AIDS Res. Hum. Retroviruses 19 (2003) 1017-1026
6. Barouch D.H., Kunstman J., Kuroda M.J., et al. Eventual AIDS vaccine failure in a rhesus monkey by viral escape from cytotoxic T lymphocytes. Nature 415 (2002) 335-339
7. Betts M.R., Ambrozak D.R., Douek D.C., et al. Analysis of total human immunodeficiency virus (HIV)-specific CD4+ and CD8+ T-cell responses: relationship to viral load in untreated HIV infection. J. Virol. 75 (2001) 11983-11991
8. Buseyne F., Blanche S., Schmitt D., Griscelli C., and Rivière Y. Detection of HIV-specific cell-mediated cytotoxicity in the peripheral blood from infected children. J. Immunol. 150 (1993) 3569-3581
9. Buseyne F., Burgard M., Teglas J.P., et al. Early Human Immunodeficiency Virus (HIV)-specific cytotoxic T lymphocytes (CTL) and disease progression in children born to HIV-infected mothers. AIDS Res. Hum. Retroviruses 14 (1998) 1435-1444
10. Buseyne F., Chaix M.L., Fleury B., et al. Cross-clade-specific cytotoxic T lymphocytes in HIV-1 infected children. Virology 250 (1998) 316-324
11. Buseyne F., Le Chenadec J., and Corre B. Inverse correlation between memory Gag-specific cytotoxic T lymphocytes and viral replication in human immunodeficiency virus-infected children. J. Infect. Dis. 186 (2002) 1589-1596
12. Buseyne F., Scott-Algara D., Porrot F., et al. Frequencies of ex vivo-activated human immunodeficiency virus type 1-specific gamma-interferon-producing CD8+ T cells in infected children correlate positively with plasma viral load. J. Virol. 76 (2002) 12414-12422
13. Buseyne F., Catteau A., Scott-Algara D., et al. A Vaccinia-based Elispot assay for detection of CD8+ T cells from HIV-1 infected children. J. Immunol. Methods 298 (2005) 105-118
14. Buseyne F., Scott-Algara D., Bellal N., et al. The frequency of HIV-specific interferon-gamma-producing CD8 T cells is associated with both age and level of antigenic stimulation in HIV-1-infected children. J. Infect. Dis. 192 (2005) 1781-1786
15. Buseyne F., Le Chenadec J., Burgard M., et al. In HIV type 1-infected children cytotoxic T lymphocyte responses are associated with greater reduction of viremia under antiretroviral therapy. AIDS Res. Hum. Retroviruses 21 (2005) 719-727
16. Cao J.H., McNevin J., Holte S., et al. Comprehensive analysis of human immunodeficiency virus type 1 (HIV-1)-specific gamma interferon-secreting CD8+ T cells in primary HIV-1 infection. J. Virol. 77 (2003) 6867-6878
17. Casartelli N., Di Matteo G., Argentini C., et al. Structural defects and variations in the HIV-1 nef gene from rapid, slow and non-progressor children. AIDS 17 (2003) 1291-1301
18. Casartelli N., Di Matteo G., Potesta M., Rossi P., and Doria M. CD4 and major histocompatibility complex class I downregulation by the human immunodeficiency virus type 1 Nef protein in pediatric AIDS progression. J. Virol. 77 (2003) 11536-11545
19. Chaix M.L., Descamps D., Harzic M., et al. Stable prevalence of genotypic drug resistance mutations but increase in non-B virus among patients with primary HIV-1 infection in France. AIDS 17 (2003) 2635-2643
20. Chandwani R., Jordan K.A., Shacklett B.L., et al. Limited magnitude and breadth in the HLA-A2-restricted CD8-T cell response to Nef in children with vertically acquired HIV-1 infection. Scand. J. Immunol. 59 (2004) 109-114
21. Chouquet C., Autran B., Gomard E., et al. Correlation between breadth of memory HIV-specific cytotoxic T cells, viral load and disease progression in HIV infection. AIDS 16 (2002) 2399-2407
22. Coplan P.M., Gupta S.B., Dubey S.A., et al. Cross-reactivity of anti-HIV-1 T cell immune responses among the major HIV-1 clades in HIV-1-positive individuals from 4 continents. J. Infect. Dis. 191 (2005) 1427-1434
23. Currier J.R., Dowling W.E., Wasunna K.M., et al. Detection of high frequencies of HIV-1 cross-subtype reactive CD8 T lymphocytes in the peripheral blood of HIV-1-infected Kenyans. AIDS 17 (2003) 2149-2157
24. Draenert R., Verrill C.L., Tang Y., et al. Persistent recognition of autologous virus by high-avidity CD8 T cells in chronic, progressive human immunodeficiency virus type 1 infection. J. Virol. 78 (2004) 630-641
25. Evans D.T., O'Connor D.H., Jing P.C., et al. Virus-specific cytotoxic T-lymphocyte responses select for amino-acid variation in simian immunodeficiency virus Env and Nef. Nat. Med. 5 (1999) 1270-1276
26. Feeney M.E., Roosevelt K.A., Tang Y., et al. Comprehensive screening reveals strong and broadly directed human immunodeficiency virus type 1-specific CD8 responses in perinatally infected children. J. Virol. 77 (2003) 7492-7501
27. Geffin R., Wolf D., Muller R., et al. Functional and structural defects in HIV type 1 nef genes derived from pediatric long-term survivors. AIDS Res. Hum. Retroviruses 16 (2000) 1855-1868
28. Goulder P.J.R., Altfeld M.A., Rosenberg E.S., et al. Substantial differences in specificity of HIV-specific cytotoxic T cells in acute and chronic HIV infection. J. Exp. Med. 193 (2001) 181-193
29. Jamieson B.D., Yang O.O., Hultin L., et al. Epitope escape mutation and decay of human immunodeficiency virus type 1-specific CTL responses. J. Immunol. 171 (2003) 5372-5379
30. Kousignian I., Autran B., Chouquet C., et al. Markov modelling of changes in HIV-specific cytotoxic T-lymphocyte responses with time in untreated HIV-1 infected patients. Stat. Med. 22 (2003) 1675-1690
31. Lichterfeld M., Yu X.G., Cohen D., et al. HIV-1 Nef is preferentially recognized by CD8 T cells in primary HIV-1 infection despite a relatively high degree of genetic diversity. AIDS 18 (2004) 1383-1392
32. Lubaki N.M., Shepherd M.E., Brookmeyer R.S., et al. HIV-1-specific cytolytic T-lymphocyte activity correlates with lower viral load, higher CD4 count, and CD8+CD38-DR- phenotype: comparison of statistical methods for measurement. JAIDS 22 (1999) 19-30
33. Luzuriaga K., McManus M., Catalina M., et al. Early therapy of vertical human immunodeficiency virus type 1 (HIV-1) infection: Control of viral replication and absence of persistent HIV-1-specific immune responses. J. Virol. 74 (2000) 6984-6991
34. Masemola A., Mashishi T., Khoury G., et al. Hierarchical targeting of subtype C human immunodeficiency virus type 1 proteins by CD8+ T cells: correlation with viral load. J. Virol. 78 (2004) 3233-3243
35. Migueles S.A., Laborico A.C., Shupert W.L., et al. HIV-specific CD8+ T cell proliferation is coupled to perforin expression and is maintained in nonprogressors. Nat. Immunol. 3 (2002) 1061-1068
36. Mofenson L.M., Korelitz J., Meyer III W.A., et al. The relationship between serum human immunodeficiency virus type 1 (HIV-1) RNA level, CD4 lymphocyte percent, and long-term mortality risk in HIV-1-infected children. J. Infect. Dis. 175 (1997) 1029-1038
37. Palumbo P.E., Raskino C., Fiscus S., et al. Predictive value of quantitative plasma HIV RNA and CD4+ lymphocyte count in HIV-infected infants and children. JAMA 279 (1998) 756-761
38. Probst H.C., Tschannen K., Gallimore A., et al. Immunodominance of an antiviral cytotoxic T cell response is shaped by the kinetics of viral protein expression. J. Immunol. 171 (2003) 5415-5422
39. Rouzioux C., Burgard M., Chaix M.L., et al. Human immunodeficiency virus-1 infection in neonates-correlation of plasma and cellular viremia and clinical outcome. Acta Paediatr. 86 (1997) 17-21
40. Sandberg J.K., Fast N.M., Jordan K.A., et al. HIV-specific CD8+ T cell function in children with vertically acquired HIV-1 infection is critically influenced by age and the state of the CD4+ T cell compartment. J. Immunol. 170 (2003) 4403-4410
41. Scott Z.A., Chadwick E.G., Gibson L.L., et al. Infrequent detection of HIV-1-specific, but not cytomegalovirus-specific, CD8+ T cell responses in young HIV-1-infected infants. J. Immunol. 167 (2001) 7134-7140
42. Shearer W.T., Quinn T.C., LaRussa P., et al. Viral load and disease progression in infants infected with human immunodeficiency virus type 1. NEJM 336 (1997) 1337-1342
43. Sol-Foulon N., Moris A., Nobile C., et al. HIV-1 nef-induced upregulation of DC-SIGN in dendritic cells promotes lymphocyte clustering and viral spread. Immunity 16 (2002) 145-155
44. Spiegel H.M., Chandwani R., Sheehy M.E., et al. The impact of early initiation of highly active antiretroviral therapy on the human immunodeficiency virus type 1-specific CD8 T cell response in children. J. Infect. Dis. 182 (2000) 88-95
45. Yang O.O., Sarkis P.T.N., Ali A., et al. Determinants of HIV-1 mutational escape from cytotoxic T lymphocytes. J. Exp. Med. 197 (2003) 1365-1375
46. Yang O.O., Sarkis P.T.N., Trocha A., et al. Impacts of avidity and specificity on the antiviral efficiency of HIV-1-specific CTL. J. Immunol. 171 (2003) 3718-3724